Ten Covid-19 vaccines could be available by the middle of next year if they get regulatory approval, but their inventors need patent protection, the head of the global pharmaceutical industry group said on Friday. Vaccines from Pfizer and BioNtech, as well as Moderna and AstraZeneca, have shown promising results in …
Read More »
Earlier this week, AstraZeneca PLC and the University of Oxford said their vaccine candidate was 62% to 90% effective, joining two other Western vaccine rivals in providing data. The results could allow the US and other countries to grant regulatory clearance and prepare distribution plans for widespread vaccination. Chinese vaccine …
Read More »
Written by Anil Sasi, edited by Explained Desk | New Delhi | Updated: November 25, 2020 5:31:57 pm In this illustration, taken on September 9, 2020, a test tube labeled with the vaccine is seen in front of the AstraZeneca logo (Reuters Photo: Dado Ruvic). Despite the overall efficacy reading …
Read More »
the coronavirus The pandemic has changed the way we buy and today, the most demanded product in the world market is the coronavirus vaccine. After months of work and hard work by scientists around the world, people finally breathe a sigh of relief with multiple COVID-19 vaccines that have successfully …
Read More »
Despite low efficiency, it is the best bet for India Dr. Jameel, stating a simple fact there. These vaccines require very cold storage. Pfizer must be stored at -70 degrees Celsius, requires specialized containers, transportation, training and distribution. Moderna vaccine can be stored at -20 degrees Celsius and can be …
Read More »
Vaccine developers have been racing against time to find a vaccine that offers immunity against the coronavirus disease (Covid-19). Oxford University announced Monday that its viral disease vaccine was up to 90% effective in preventing infections, Pfizer Inc. applied for an emergency use authorization in the US for its vaccine …
Read More »
Interim Phase 3 analysis of the Oxford / AstraZeneca Covid-19 vaccine candidate showed a 70.4 percent efficacy in preventing the disease, Oxford University announced on Monday. At two different dosing regimens, the vaccine, AZD1222, was 90% and 62% effective. In the most effective dosing regimen, AZD1222 was administered as a …
Read More »
Pfizer applied for an emergency use authorization in the US on Friday and can begin implementation in mid-December. The successes of the trials by Pfizer Inc. and Moderna Inc. have fueled hopes that a Covid-19 vaccine will soon arrive. But much of the world, outside of wealthy nations like the …
Read More »
As the race to develop and distribute a potential Covid-19 vaccine accelerates around the world, Russian coronavirus vaccine candidate Sputnik V, also touted as the world’s first registered Covid-19 vaccine, will have a price ‘much lower’ than other covid vaccines like the Pfizer and Modern candidates, according to the developers …
Read More »
Moderna has said that its experimental vaccine is 94.5% effective in preventing COVID-19 Frankfurt: Moderna will charge governments between $ 25 and $ 37 per dose of its COVID-19 vaccine candidate, depending on the amount requested, Chief Executive Stephane Bancel told the German weekly Welt am Sonntag (WamS). “So our …
Read More »